MarketTwits
265K subscribers
78.3K photos
2.93K videos
1.1K files
82.8K links
Вся информация на канале не является рекомендацией

связь - @MarketTwits_info
связь - [email protected]
VK - https://vk.com/id635239814

в подборках не участвуем, партнерки не практикуем, свой канал не рекламируем, менеджеры по рекламе не нужны
Download Telegram
🇺🇸#акции #сша #premarket
премаркет США - акции - заметные движения:

ВВЕРХ

#LTM +46% LATAM Airlines Group S.A. - after Delta Air Lines announced plans to invest $1.9 billion for 20% stake in Latam Airlines through public tender offer at $16 per share.

#AGTC +18% Applied Genetic Technologies Corporation-after reporting Q4 results. BMO Capital upgraded Applied Genetic Tech from Market Perform to Outperform and raised the price target from $5 to $9.

#SNDL +10% Sundial Growers Inc. - after declining 20% on Thursday.

#VNRX +9% VolitionRx Limited - after dropping 8% on Thursday.

#GLBS +7% Globus Maritime Limited - expected to release quarterly earnings after the closing bell.

#AVXL +6% Anavex Life Sciences Corp. - presented detailed preliminary efficacy data from the pharmacokinetic cohort —Part A —of the Phase 2 study for AVANEX 2-73 in Rett syndrome at the 6th European Rett Syndrome Conference. The company said the results are encouraging.

#LVS +5% Las Vegas Sands Corp. - after the company was added to the S&P 500 index.

#TME +5% Tencent Music Entertainment Group

#SGH +5% SMART Global Holdings, Inc.. - after dropping 9% on Thursday.

#MNT +4% Vail Resorts, Inc. - after the company reported better-than-expected results for its fourth quarter on Thursday.

#MTCH +4% Match Group, Inc. - Evercore ISI Group upgraded Match Group from In-Line to Outperform.

#FTCH +4% Farfetch Limited

#WFC +3% Wells Fargo & Co - after the company named Charles Scharf as president and CEO. Mr. Scharf is a banking veteran and the market may perceive this as a good sign for the company's outlook.

ВНИЗ

#PRGS -12% Progress Software Corporation - reported stronger-than-expected earnings for its third quarter and raised its quarterly dividend from $0.15 to $0.16. However, the company issued weak sales forecast for FY19.

#VSLR -7% Vivint Solar, Inc. -after declining 8% on Thursday.

#ATRA -7% Atara Biotherapeutics, Inc. -Goldman Sachs downgraded Atara Biotherapeutics from Neutral to Sell and lowered the price target from $14 to $9.

#ATHM -5% Autohome Inc.

#MU -5% Micron Technology, Inc. - reported upbeat results for its fourth quarter. The company guided to first-quarter adjusted EPS of 39-53 cents and sales of $4.8-$5.2 billion.

#AYTU -5% Aytu Bioscience Inc - after reporting FY19 EPS and sales results.

#BOX -5% Box, Inc. - JP Morgan downgraded Box from Neutral to Underweight.

#RSAD -4% Rite Aid Corporation

#WTI -4% W&T Offshore, Inc.

#CAMP -4% CalAmp Corp. - following Q2 results.

#PHG -4% Koninklijke Philips N.V.

#GSL -3% Global Ship Lease, Inc. - priced upsized 6.6 million share public offering of class A common shares at $7.25 per share.
🇺🇸#premarket #сша
премаркет США - акции - заметные движения:

ВВЕРХ
#NNDM +64% Nano Dimension Ltd. - shares surged 342% on Tuesday after the company and HENSOLDT achieved a major breakthrough in electronics 3D printing.
#CYRN +55% CYREN Ltd. - after gaining around 7% on Tuesday.
#ALDX +50% Aldeyra Therapeutics, Inc. - expected to issue a COVID-19 development update today.
#XELB +49% Xcel Brands, Inc. - reported better-than-expected results for its first quarter.
#PAE +48% PAE Incorporated - the company won a National Aviation Maintenance and Logistics Services contract by the US Customs and Border Protection.
#SFET +40% Safe-T Group Ltd - reported new cyber-security sector deals by its wholly owned subsidiary, NetNut Ltd.
#STAF +31% Staffing 360 Solutions, Inc. - after declining around 6% on Tuesday.
#BOXL +30% Boxlight Corporation -after surging over 18% on Tuesday.
#INO +30% Inovio Pharmaceuticals Inc - after the company said COVID-19 coronavirus DNA vaccine INO-4800 demonstrates 'robust neutralizing antibody and T cell immune responses in preclinical models.'
#SURF +23% Surface Oncology, Inc.
#SGLB +20% Sigma Labs, Inc. -after jumping around 19% on Tuesday. Sigma Labs named Mark K. Ruport as CEO and president on Tuesday.
#LOW +8% Lowe's Companies, Inc. -after reporting better-than-expected Q1 results.
#FSLY +6% Fastly, Inc.
#FDP +6% Fresh Del Monte Produce Inc.
#MDWD +6% Mediwound Ltd - following upbeat quarterly results.
#NNVC +6% NanoViricides, Inc. - the company said 'strong effectiveness' has been observed in animal model for the drug candidates it is developing against SARS-CoV-2 for coronavirus.
#RDY +6% Dr. Reddy's Laboratories Limited - after reporting upbeat quarterly earnings.

ВНИЗ
#PYX -29% Pyxus International, Inc. - after declining around 5% on Tuesday.
#PIXY -19% ShiftPixy, Inc. - shares jumped 52% on Tuesday after the company announced a deal with Diamondback DTNM, an operator of 11 Del Taco Restaurants.
#MDGS -17% Medigus Ltd. - announced a proposed ADS public offering.
#OGEN -17% Oragenics, Inc. - shares surged over 21% on Tuesday after the company announced it entered into an agreement with Aragen Biosciences to accelerate the development of TerraCoV2, a potential coronavirus vaccine candidate.
#KMPH -13% KemPharm, Inc. - shares climbed over 13% on Tuesday after the company received a Day-74 letter which stated that the New Drug Application for its KP415 is sufficiently complete to permit a substantive review by the FDA.
#VNRX -13% VolitionRx Limited - after reporting an offering of common stock.
#RTTR -11% Ritter Pharmaceuticals, Inc. -after declining 19% on Tuesday. Ritter Pharmaceuticals reported stockholder approval of proposals required for merger transaction with Qualigen, Inc.
#BLIN -10% Bridgeline Digital, Inc.
#ACER -10% Acer Therapeutics Inc. - after jumping around 30% on Tuesday.
#IVR -9% Invesco Mortgage Capital Inc. -after gaining around 6% on Tuesday.
#SM -6% SM Energy Company
#CABO -5% Cable One, Inc. - reported a $400 million common stock offering on Tuesday.
#MRNA -4% Moderna, Inc. - company claims on achieving a dose-dependent increase in immunogenicity in Phase 1 trials of its COVID-19 vaccine candidate, mRNA-1273, are not backed by sufficient data, according to vaccine experts.